Cibus Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
51.4%projected annual EPS growth
Analyst Coverage
3analysts covering
FY EPS (est.)
-$0.73next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 12 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Annual Net Cash Usage Annually30MTarget: 30000000 or less
Rice Herbicide Tolerance (HT1 and HT3) Peak Addressable Acres AnnuallyTarget: 5,000,000 to 7,000,000 acres
Rice Herbicide Tolerance Peak Annual Royalty Revenue Annually
Watch Items
- Commercial launch of Rice Herbicide Tolerance traits in Latin AmericaTrigger: Targeted launch timeline of 2027Action: Monitor regulatory approvals, import permits, and customer seed transfers (e.g., Interoc in LATAM).
- Commercial launch of Rice Herbicide Tolerance traits in the United StatesTrigger: Targeted launch timeline of 2028Action: Track expansion of customer relationships with US rice seed companies and field trial validations.
- Sustainable Ingredients Biofragrance CommercializationTrigger: Initial revenue recognition targeted for 2026Action: Monitor scale-up orders in the second half of 2026 and progressing R&D activities with partners.
- Cash Runway and Capital SufficiencyTrigger: Cash runway expected to fund operations into late Q1 2027Action: Evaluate cash burn rate relative to the $30.3 million cash balance as of March 31, 2026, and assess potential dilutive or non-dilutive financing needs.
Research as of 19 Jun 2026